Mobic and Vimpat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mobic and Vimpat. Common interactions include convulsion among females and ankle fracture among males.

The phase IV clinical study analyzes what interactions people who take Mobic and Vimpat have. It is created by eHealthMe based on reports of 31 people who take Mobic and Vimpat from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 04, 2022

31 people who take Mobic and Vimpat together, and have interactions are studied.


What is Mobic?

Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 25,681 Mobic users for its effectiveness, alternative drugs and more.

What is Vimpat?

Vimpat has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 17,791 Vimpat users for its effectiveness, alternative drugs and more.

Number of Mobic and Vimpat reports submitted per year:

Mobic and Vimpat drug interactions.

Common Mobic and Vimpat drug interactions by gender *:

female:

  1. Convulsion
  2. Depressed level of consciousness
  3. Diarrhoea
  4. Drug hypersensitivity
  5. Drug intolerance
  6. Dry skin
  7. Dysphagia
  8. Dysphoria
  9. Dystonia
  10. Ear pain

male:

  1. Ankle fracture
  2. Arthralgia
  3. Ligament disorder
  4. Lower limb fracture
  5. Pain in extremity
  6. Surgery
  7. Chest pain
  8. Cough
  9. Headache
  10. Hospitalisation

Common Mobic and Vimpat drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Blood creatine phosphokinase increased

30-39:

n/a

40-49:

  1. Fall
  2. Cellulitis
  3. Dizziness
  4. Pruritus
  5. Wrist fracture
  6. Arthralgia
  7. Pain in extremity
  8. Ankle fracture
  9. Dependence
  10. Disability

50-59:

  1. Incontinence
  2. Lethargy
  3. Leukocytosis
  4. Malaise
  5. Mobility decreased
  6. Postictal state
  7. Respiratory failure
  8. Secondary progressive multiple sclerosis
  9. Cerebellar atrophy
  10. Disturbance in attention

60+:

  1. Headache
  2. Rhinorrhoea
  3. Abdominal pain
  4. Adverse reaction
  5. Anaphylactic reaction
  6. Appetite disorder
  7. Arthralgia
  8. Arthritis infective
  9. Asthenia
  10. Back pain

Common conditions people have *:

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 9 people, 29.03%
  2. Pain: 9 people, 29.03%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 22.58%
  4. Sleep Disorder: 5 people, 16.13%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 16.13%
  6. Restless Leg Syndrome (a powerful urge to move your legs): 3 people, 9.68%
  7. Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 3 people, 9.68%
  8. Neuropathy Peripheral (surface nerve damage): 3 people, 9.68%
  9. Headache (pain in head): 3 people, 9.68%
  10. High Blood Pressure: 3 people, 9.68%

* Approximation only. Some reports may have incomplete information.

Do you take Mobic and Vimpat?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Mobic and Vimpat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Mobic interactions:

Browse all interactions between Mobic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Vimpat interactions:

Browse all interactions between Vimpat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on meloxicam and lacosamide (the active ingredients of Mobic and Vimpat, respectively), and Mobic and Vimpat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Mobic and Vimpat.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: